Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

RTTNews | 858天前
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.

EGFR inhibitors are critical therapeutic agents for the treatment of non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer, squamous-cell carcinoma of the head and neck, and breast cancer.

The company said this trial brings us one step closer to a new treatment option for underserved cancer patients as there is no specific treatment currently approved for the treatment of skin toxicities associated with EGFRi therapies.

The company added it will advance HT-001 into the clinical phase as it is a key treatment in the onco-dermatology space and anticipates beginning the Phase 2a trial in the first quarter of 2023.

read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | 602天前
Pound Weakens In Cautious Trade

Pound Weakens In Cautious Trade

The pound dropped against its most major counterparts in the New York session on Monday amid renewed trade concerns, as President Donald Trump announced plans to impose a 100 percent tariff on movies produced in foreign countries.
RTTNews | 2小时49分钟前
Swiss Market Ends Marginally Down After Choppy Session

Swiss Market Ends Marginally Down After Choppy Session

Despite staying positive for much of the day's trading session, the Switzerland market closed slightly weak on Monday with a few stocks turning weak past mid afternoon, as investors turned cautious amid a lack of prominent triggers.
RTTNews | 3小时31分钟前
European Stocks Closed Mixed After Cautious Session

European Stocks Closed Mixed After Cautious Session

European stocks turned in a mixed performance on Monday with investors closely following developments on the trade front, and continuing to react to quarterly earnings updates from big name European companies.
RTTNews | 3小时55分钟前
Canadian Stocks Largely Subdued In Cautious Trade

Canadian Stocks Largely Subdued In Cautious Trade

After a slightly weak start and a subsequent drop to lower levels, the Canadian market recovered some lost ground Monday morning, but still struggles to move any significantly above the flat line.
RTTNews | 4小时24分钟前
U.S. Services Index Unexpectedly Increases In April

U.S. Services Index Unexpectedly Increases In April

A report released by the Institute for Supply Management on Monday showed an unexpected increase by its reading on U.S. service sector activity in the month of April. The ISM said its services PMI rose to 51.6 in April from 50.8 in March, with a reading above 50 indicating growth. Economists had expected the index to edge down to 50.6.
RTTNews | 6小时10分钟前